MX340620B - Inhibicion de efectos sensoriales no deseados a traves del compuesto de alcanfor. - Google Patents
Inhibicion de efectos sensoriales no deseados a traves del compuesto de alcanfor.Info
- Publication number
- MX340620B MX340620B MX2012011150A MX2012011150A MX340620B MX 340620 B MX340620 B MX 340620B MX 2012011150 A MX2012011150 A MX 2012011150A MX 2012011150 A MX2012011150 A MX 2012011150A MX 340620 B MX340620 B MX 340620B
- Authority
- MX
- Mexico
- Prior art keywords
- inhibition
- camphor
- sensory effects
- undesired sensory
- compound camphor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/186—Treatment of tobacco products or tobacco substitutes by coating with a coating composition, encapsulation of tobacco particles
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/34—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring
- A24B15/345—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring containing condensed rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un producto de tabaco sin humo (10, 100) o un producto de nicotina medicinal comprende nicotina y alcanfor disuelto en un vehículo oleoso sin sabor. Preferiblemente, el alcanfor está presente en una concentración que varía de aproximadamente 600 a aproximadamente 1300 ppm. También, se describen métodos para elaborar dichos productos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31825310P | 2010-03-26 | 2010-03-26 | |
PCT/IB2011/000994 WO2011117735A2 (en) | 2010-03-26 | 2011-03-28 | Inhibition of undesired sensory effects by the compound camphor |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012011150A MX2012011150A (es) | 2013-03-05 |
MX340620B true MX340620B (es) | 2016-07-18 |
Family
ID=44486992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012011150A MX340620B (es) | 2010-03-26 | 2011-03-28 | Inhibicion de efectos sensoriales no deseados a traves del compuesto de alcanfor. |
Country Status (14)
Country | Link |
---|---|
US (4) | US8952038B2 (es) |
EP (1) | EP2552244B1 (es) |
JP (1) | JP5886823B2 (es) |
KR (1) | KR101760972B1 (es) |
BR (1) | BR112012024364A2 (es) |
CA (1) | CA2794638C (es) |
DK (1) | DK2552244T3 (es) |
EC (1) | ECSP12012251A (es) |
MX (1) | MX340620B (es) |
MY (1) | MY165804A (es) |
PL (1) | PL2552244T3 (es) |
RU (1) | RU2012145537A (es) |
UA (1) | UA110029C2 (es) |
WO (1) | WO2011117735A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011117740A2 (en) | 2010-03-26 | 2011-09-29 | Philip Morris Products S.A. | Inhibition of sensory irritation during consumption of non-smokeable tobacco products |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
US8646461B2 (en) | 2011-12-14 | 2014-02-11 | Sentiens, Llc | Device and method for simulating chemosensation of smoking |
SE536491C2 (sv) | 2012-03-26 | 2013-12-27 | Bionicotine Ab | Påse innehållande nikotin och en tuggummikomposition |
US10335378B2 (en) * | 2013-03-15 | 2019-07-02 | Altria Client Services Llc | Inhibition of central nervous system effects from smoking and sensory effects from smoking |
US9538782B2 (en) * | 2013-03-15 | 2017-01-10 | Altria Client Services Llc | Inhibition of sensory irritation during consumption of smokeless tobacco products using a combinatorial approach |
US10130120B2 (en) | 2013-03-15 | 2018-11-20 | Altria Client Services Llc | Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products |
WO2015157359A1 (en) | 2014-04-08 | 2015-10-15 | Altria Client Services Llc | Tobacco having altered leaf properties and methods of making and using |
US20220087997A1 (en) * | 2020-09-22 | 2022-03-24 | Fertin Pharma A/S | Oral Antagonist Compositions For Nicotine Burning Relief |
Family Cites Families (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4198309A (en) * | 1977-11-15 | 1980-04-15 | International Flavors & Fragrances Inc. | Use of trans, trans-Δ-damascone and mixtures containing 80% or more of trans, trans-Δ-damascone in augmenting or enhancing the aroma of a detergent |
US4211242A (en) * | 1977-11-15 | 1980-07-08 | International Flavors & Fragrances Inc. | Composition of matter comprising more than 50% trans, trans-Δ-damascone for augmenting or enhancing the aroma and taste of a smoking tobacco |
US4275251A (en) * | 1980-04-29 | 1981-06-23 | International Flavors & Fragrances Inc. | Substituted tricyclodecane derivatives, processes for producing same and organoleptic uses thereof |
US4378380A (en) | 1980-10-10 | 1983-03-29 | General Foods Corporation | Method for producing products enhanced with synthetic coffee grinder gas flavor |
US4351347A (en) * | 1981-03-25 | 1982-09-28 | International Flavors & Fragrances Inc. | Organoleptic uses of norbornyl ethers and esters |
US5820876A (en) | 1986-08-28 | 1998-10-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system |
USRE37934E1 (en) | 1986-08-28 | 2002-12-10 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system |
US6126963A (en) | 1986-08-28 | 2000-10-03 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system, its use and production process |
IL86170A (en) | 1987-05-01 | 1992-12-01 | Elan Transdermal Ltd | Preparations and compositions comprising nicotine for percutaneous administration |
DE3827561C1 (es) | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
US4959380A (en) | 1988-12-19 | 1990-09-25 | Wilson Jordan E | Method of treating people to stop smoking and composition |
US5167244A (en) * | 1990-01-19 | 1992-12-01 | Kjerstad Randy E | Tobacco substitute |
CA2053462A1 (en) | 1990-10-22 | 1992-04-23 | Yoshiaki Yano | Sticky composition for medical use |
DE4301782C1 (de) | 1993-01-23 | 1994-08-25 | Lohmann Therapie Syst Lts | Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit |
JPH0782588A (ja) * | 1993-09-14 | 1995-03-28 | Sanei Gen F F I Inc | 香気放出調整法 |
DE4341444C2 (de) | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung |
US5505958A (en) | 1994-10-31 | 1996-04-09 | Algos Pharmaceutical Corporation | Transdermal drug delivery device and method for its manufacture |
US5716621A (en) | 1996-07-03 | 1998-02-10 | Pharmadyn, Inc. | Nonocclusive drug delivery device and process for its manufacture |
DE19635676A1 (de) | 1996-09-03 | 1998-03-05 | Basf Ag | Feste geschäumte Wirkstoffzubereitungen |
US6949264B1 (en) | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
CA2216215A1 (en) | 1997-04-05 | 1998-10-05 | Isa Odidi | Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity |
EP1021204B1 (en) | 1997-09-26 | 2005-12-28 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
US20020017295A1 (en) | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
CN1044314C (zh) | 1997-12-01 | 1999-07-28 | 蒲邯名 | 健身香烟 |
CN1143629C (zh) * | 1998-02-09 | 2004-03-31 | 罗梭研究股份有限公司 | 含维生素e的烟草制品及制造方法 |
JPH11313634A (ja) | 1998-03-12 | 1999-11-16 | Internatl Flavors & Fragrances Inc <Iff> | 呈味剤とその製造方法 |
US6270804B1 (en) | 1998-04-03 | 2001-08-07 | Biovail Technologies Ltd. | Sachet formulations |
US6103266A (en) | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
US6316011B1 (en) | 1998-08-04 | 2001-11-13 | Madash, Llc | End modified thermal responsive hydrogels |
DE19843904A1 (de) | 1998-09-24 | 2000-03-30 | Basf Ag | Feste Dosierungsform mit polymerem Bindemittel |
US6165512A (en) | 1998-10-30 | 2000-12-26 | Fuisz Technologies Ltd. | Dosage forms containing taste masked active agents |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
US7163705B2 (en) | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
DE19906979B4 (de) | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
TWI233810B (en) | 1999-02-19 | 2005-06-11 | Hisamitsu Pharmaceutical Co | A paster sheet |
US6183770B1 (en) | 1999-04-15 | 2001-02-06 | Acutek International | Carrier patch for the delivery of agents to the skin |
US7063859B1 (en) | 1999-04-28 | 2006-06-20 | Noven Pharmaceuticals, Inc. | Barrier film lined backing layer composition and method for topical administration of active agents |
US6277401B1 (en) | 1999-05-07 | 2001-08-21 | U.S. Dermatologics, Inc. | Drug delivery device |
DE19923427A1 (de) | 1999-05-21 | 2000-11-23 | Lohmann Therapie Syst Lts | Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen |
DE19932603A1 (de) | 1999-07-13 | 2001-01-25 | Gruenenthal Gmbh | Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren |
US6582724B2 (en) | 1999-12-16 | 2003-06-24 | Dermatrends, Inc. | Dual enhancer composition for topical and transdermal drug delivery |
US6821953B1 (en) | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
AU3104301A (en) | 2000-01-20 | 2001-07-31 | Noven Pharmaceuticals, Inc. | Compositions and methods to effect the release profile in the transdermal administration of active agents |
US6953593B2 (en) | 2000-02-01 | 2005-10-11 | Lipoprotein Technologies, Inc. | Sustained-release microencapsulated delivery system |
WO2001089476A1 (en) * | 2000-05-19 | 2001-11-29 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
ES2286026T3 (es) * | 2000-06-26 | 2007-12-01 | Glycanex B.V. | Metodos y dispositivos para eliminar las toxinas nucleofilas del tabaco y del humo del tabaco. |
DE10032456A1 (de) | 2000-07-04 | 2002-01-31 | Lohmann Therapie Syst Lts | Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen |
DE10053375C1 (de) | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
US6682757B1 (en) | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
BR0207955A (pt) | 2001-03-07 | 2004-02-25 | Hisamitsu Pharmaceutical Co | Agente de emplastro |
US6834654B2 (en) * | 2001-05-01 | 2004-12-28 | Regent Court Technologies, Llc | Smokeless tobacco product |
US6668839B2 (en) | 2001-05-01 | 2003-12-30 | Jonnie R. Williams | Smokeless tobacco product |
JP4324465B2 (ja) | 2001-06-12 | 2009-09-02 | 久光製薬株式会社 | シート状貼付剤 |
US6789546B2 (en) | 2001-06-26 | 2004-09-14 | Technion Research & Development Foundation Ltd. | Filters for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject |
US20040224012A1 (en) | 2001-10-05 | 2004-11-11 | Pichit Suvanprakorn | Topical application and methods for administration of active agents using liposome macro-beads |
US6893655B2 (en) | 2001-10-09 | 2005-05-17 | 3M Innovative Properties Co. | Transdermal delivery devices |
DE60105820D1 (de) | 2001-10-22 | 2004-10-28 | Pera Ivo E | Zusammensetzung zur Reduzierung oder Entwöhnung von Nikotinabhängigkeit |
EP1441603A2 (en) * | 2001-11-09 | 2004-08-04 | Vector Tobacco Inc. | Method and composition for mentholation of charcoal filtered cigarettes |
GB0130518D0 (en) | 2001-12-21 | 2002-02-06 | Univ Gent | Pulsed bio-agent delivery systems based on degradable polymer solutions or hydrogels |
US6750291B2 (en) | 2002-04-12 | 2004-06-15 | Pacific Corporation | Film-forming agent for drug delivery and preparation for percutaneous administration containing the same |
AR033748A1 (es) | 2002-05-15 | 2004-01-07 | Thalas Group Inc | Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo |
JP4199485B2 (ja) | 2002-06-07 | 2008-12-17 | 久光製薬株式会社 | 貼付剤 |
WO2003103673A1 (en) | 2002-06-10 | 2003-12-18 | Purdue Pharma, L.P. | Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
JP4792193B2 (ja) | 2002-08-28 | 2011-10-12 | 久光製薬株式会社 | 貼付剤 |
SE0302947D0 (sv) | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
EA012306B1 (ru) * | 2003-01-24 | 2009-08-28 | Магле Холдинг Аб | Композиционный материал для доставки через слизистые оболочки |
JP2004229627A (ja) * | 2003-01-29 | 2004-08-19 | Yoshiaki Fujiyama | 鼻で吸うタバコ代用物 |
US20040202708A1 (en) | 2003-04-14 | 2004-10-14 | 3M Innovative Properties Company | Transdermal drug delivery device with translucent inorganic barrier layer |
US20040219198A1 (en) | 2003-05-01 | 2004-11-04 | 3M Innovative Properties Company | Transdermal drug delivery device with multilayer backing |
WO2005011683A1 (ja) | 2003-08-04 | 2005-02-10 | Kyorin Pharmaceutical Co., Ltd. | 経皮吸収型製剤 |
WO2005041151A2 (en) | 2003-10-02 | 2005-05-06 | Vector Tobacco Ltd. | Tobacco product labeling system |
US20050118246A1 (en) | 2003-10-31 | 2005-06-02 | Wong Patrick S. | Dosage forms and layered deposition processes for fabricating dosage forms |
WO2005048964A1 (en) | 2003-11-12 | 2005-06-02 | Symrise Gmbh & Co. Kg | Mixture with wintergreen odor and flavor |
DE10356925B4 (de) | 2003-12-05 | 2006-05-11 | Lts Lohmann Therapie-Systeme Ag | Inhalator für basische pharmazeutische Wirkstoffe sowie Verfahren für dessen Herstellung |
US20050136112A1 (en) | 2003-12-19 | 2005-06-23 | Pediamed Pharmaceuticals, Inc. | Oral medicament delivery system |
CN1579258A (zh) | 2004-05-18 | 2005-02-16 | 王自勇 | 一种新型鼻烟及其制作方法 |
US7923585B2 (en) | 2004-05-31 | 2011-04-12 | Takasago International Corporation | Menthol derivative and cooling agent composition comprising the same |
EP1807033B1 (en) | 2004-10-08 | 2016-07-20 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
EP1817034A1 (en) | 2004-10-25 | 2007-08-15 | Schering Corporation | M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders |
US20060110415A1 (en) | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
DE602005019094D1 (de) | 2004-12-22 | 2010-03-11 | Memory Pharmaceutical Corp | Nikotinische alpha-7-rezeptorliganden gegen erkrankungen des zns |
EP1835886A1 (en) | 2004-12-23 | 2007-09-26 | Warner-Lambert Company LLC | Orally disintegrating pharmaceutical compositions with sensory cue agents |
US7534454B2 (en) | 2004-12-28 | 2009-05-19 | Arun Kumar Karerat | Anti-cigarette herbal formulation as an antidote to tobacco |
US20060228418A1 (en) | 2005-04-12 | 2006-10-12 | Aquegel Cosmetics, Llc | Topical ointment and method for making and using same |
US20070026025A1 (en) | 2005-04-12 | 2007-02-01 | Aquegel Cosmetics, Llc | Topical ointment and method for making and using same |
US9044049B2 (en) | 2005-04-29 | 2015-06-02 | Philip Morris Usa Inc. | Tobacco pouch product |
BRPI0611153B1 (pt) | 2005-04-29 | 2018-02-27 | Philip Morris Products S.A. | Produto de bolsa para tabaco |
US20090175982A1 (en) | 2005-05-23 | 2009-07-09 | Cadbury Adams Usa Llc., | Methods for managing release of one or more ingredients in an edible composition |
US7186958B1 (en) | 2005-09-01 | 2007-03-06 | Zhao Wei, Llc | Inhaler |
US20070074733A1 (en) | 2005-10-04 | 2007-04-05 | Philip Morris Usa Inc. | Cigarettes having hollow fibers |
AU2007224586A1 (en) | 2006-03-16 | 2007-09-20 | Niconovum Ab | Stable lozenge compositions providing rapid release of nicotine |
US20080063748A1 (en) | 2006-09-08 | 2008-03-13 | Cadbury Adams Usa Llc. | Center-fill confectionery and chewing gum compositions containing suspended saccharide particles |
US20080102157A1 (en) | 2006-10-25 | 2008-05-01 | Steffen Hofacker | Flavored chewable foams and a process for their production |
US9032971B2 (en) | 2006-11-15 | 2015-05-19 | Philip Morris Usa Inc. | Moist tobacco product and method of making |
US20080131467A1 (en) | 2006-11-30 | 2008-06-05 | Dennis Nelson | Film-coated solid dosage form |
US20080247957A1 (en) * | 2007-02-16 | 2008-10-09 | Drexel University | Advanced drug delivery strategy and platform for minimally-invasive treatment of liver cancer |
US8616221B2 (en) | 2007-02-28 | 2013-12-31 | Philip Morris Usa Inc. | Oral pouch product with flavored wrapper |
US20090032040A1 (en) | 2007-03-30 | 2009-02-05 | Luzenberg Jr Robert S | Porous plastic smokeless tobacco substitutes |
US20080299249A1 (en) | 2007-06-01 | 2008-12-04 | Cadbury Adams Usa Llc | Center-fill gum compositions incorporating triacetin |
US8901024B2 (en) | 2007-08-02 | 2014-12-02 | The Trustees Of Columbia University In The City Of New York | Ozone-treated carbon electrodes |
US8312886B2 (en) | 2007-08-09 | 2012-11-20 | Philip Morris Usa Inc. | Oral tobacco product having a hydrated membrane coating and a high surface area |
JP2009148233A (ja) * | 2007-12-21 | 2009-07-09 | Japan Tobacco Inc | 喫煙物品 |
US8469037B2 (en) | 2008-02-08 | 2013-06-25 | Philip Morris Usa Inc. | Pre-portioned moist product and method of making |
US20100018883A1 (en) * | 2008-07-28 | 2010-01-28 | Pankaj Patel | Smokeless tobacco products and processes |
JP2011529343A (ja) * | 2008-07-28 | 2011-12-08 | アール・ジエイ・レイノルズ・タバコ・カンパニー | 無煙タバコ製品およびプロセス |
WO2011117740A2 (en) * | 2010-03-26 | 2011-09-29 | Philip Morris Products S.A. | Inhibition of sensory irritation during consumption of non-smokeable tobacco products |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
US9474303B2 (en) * | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
CN104080898A (zh) * | 2012-01-25 | 2014-10-01 | 日本烟草产业株式会社 | 烟臭口气改善香料组合物 |
-
2011
- 2011-03-25 US US13/071,889 patent/US8952038B2/en active Active
- 2011-03-28 MX MX2012011150A patent/MX340620B/es active IP Right Grant
- 2011-03-28 JP JP2013500607A patent/JP5886823B2/ja active Active
- 2011-03-28 MY MYPI2012004246A patent/MY165804A/en unknown
- 2011-03-28 RU RU2012145537/12A patent/RU2012145537A/ru unknown
- 2011-03-28 WO PCT/IB2011/000994 patent/WO2011117735A2/en active Application Filing
- 2011-03-28 UA UAA201211485A patent/UA110029C2/ru unknown
- 2011-03-28 KR KR1020127028126A patent/KR101760972B1/ko active IP Right Grant
- 2011-03-28 EP EP11723116.7A patent/EP2552244B1/en active Active
- 2011-03-28 BR BR112012024364-0A patent/BR112012024364A2/pt not_active IP Right Cessation
- 2011-03-28 CA CA2794638A patent/CA2794638C/en active Active
- 2011-03-28 PL PL11723116T patent/PL2552244T3/pl unknown
- 2011-03-28 DK DK11723116.7T patent/DK2552244T3/en active
-
2012
- 2012-10-11 EC ECSP12012251 patent/ECSP12012251A/es unknown
-
2015
- 2015-01-07 US US14/591,485 patent/US10201180B2/en active Active
-
2019
- 2019-01-02 US US16/237,956 patent/US11388923B2/en active Active
-
2022
- 2022-05-24 US US17/751,959 patent/US20220361555A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112012024364A2 (pt) | 2020-08-11 |
JP5886823B2 (ja) | 2016-03-16 |
MX2012011150A (es) | 2013-03-05 |
US10201180B2 (en) | 2019-02-12 |
WO2011117735A2 (en) | 2011-09-29 |
CA2794638A1 (en) | 2011-09-29 |
JP2013523090A (ja) | 2013-06-17 |
DK2552244T3 (en) | 2018-03-19 |
CA2794638C (en) | 2018-05-29 |
WO2011117735A8 (en) | 2011-11-10 |
KR20130029067A (ko) | 2013-03-21 |
ECSP12012251A (es) | 2012-11-30 |
KR101760972B1 (ko) | 2017-07-24 |
US20150126561A1 (en) | 2015-05-07 |
US11388923B2 (en) | 2022-07-19 |
US20220361555A1 (en) | 2022-11-17 |
US20190133175A1 (en) | 2019-05-09 |
US20120052021A1 (en) | 2012-03-01 |
PL2552244T3 (pl) | 2018-07-31 |
MY165804A (en) | 2018-04-27 |
US8952038B2 (en) | 2015-02-10 |
RU2012145537A (ru) | 2014-05-10 |
UA110029C2 (uk) | 2015-11-10 |
EP2552244A2 (en) | 2013-02-06 |
WO2011117735A3 (en) | 2012-05-18 |
EP2552244B1 (en) | 2018-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX340620B (es) | Inhibicion de efectos sensoriales no deseados a traves del compuesto de alcanfor. | |
PH12016501134A1 (en) | Filter with improved hardness and filtration efficiency | |
MX350636B (es) | Inhibicion de irritacion sensorial durante el consumo de productos de tabaco no fumables. | |
MX368781B (es) | Compuesto inhibidor de las actividades de las cinasas btk y/o jak3. | |
EA201290809A1 (ru) | Аэрозоль-генерирующий субстрат для курительных изделий | |
IN2014MN02106A (es) | ||
MX2015012731A (es) | Procesos e intermedios para preparar un medicamento. | |
MX337611B (es) | Compuestos para el tratamiento de la adiccion. | |
GEP20115342B (en) | New diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them | |
MY166210A (en) | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition | |
WO2012138713A3 (en) | Multifunctional radical quenchers for the treatment of mitochondrial dysfunction | |
UA114307C2 (uk) | Тютюновмісний виріб | |
MX2010002506A (es) | Compuestos de nicotinamida sustituidos y uso de estos en medicamentos. | |
ATE526015T1 (de) | Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien | |
PH12017500563A1 (en) | Stabilized adrenomedullin derivatives and use thereof | |
EA201291405A1 (ru) | Продукт, содержащий катехины | |
MY148732A (en) | Triazolium salts as par1 inhibitors, production thereof, and use as medicaments | |
MY152685A (en) | Imidazopyridazines as par1 inhibitors, production thereof, and use thereof as medicaments | |
SMT201300112B (it) | Sale citrato di 9E-15-(2-pirrolidin-1-il-etossi)-7,12,25-triossa-19,21,24-triaza-tetracicloÄ18.3.1.1(2,5).1(14,18)Üesacos a-1(24),2,4,9,14,16,18(26),20,22-nonaene | |
WO2010040862A3 (en) | New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer | |
EA201490270A1 (ru) | Ингибиторы aldh-2 для лечения зависимости | |
TH145024A (th) | การยับยั้งผลจากระบบรับความรู้สึกที่ไม่ต้องการโดยสารประกอบแคมฟอร์ | |
TW200716090A (en) | Inhibitors of soluble adenylate cyclase | |
MD408Y (en) | Method for prophylaxis and treatment of ectoparasitosis in hens | |
PH12015502000A1 (en) | Processes and intermediates for preparing a medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |